The WACC of Akero Therapeutics Inc (AKRO) is 9.8%.
| Range | Selected | |
| Cost of equity | 7.90% - 11.80% | 9.85% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.9% - 11.7% | 9.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.88 | 1.25 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.90% | 11.80% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.9% | 11.7% |
| Selected WACC | 9.8% | |